Literature DB >> 11982716

Endoscopic mucosal resection for esophageal and gastric cancers.

Haruhiro Inoue1, Norio Fukami, Tatsuya Yoshida, Shin-Ei Kudo.   

Abstract

Better outcomes for digestive tract cancers are likely to be possible if the tumors are detected in their earliest stages, particularly when they exist as mucosal lesions without lymph node metastases. Early esophageal squamous cell cancers can be detected with high sensitivity and specificity by iodine staining. Only mucosal cancers are suitable for the curative approach of submucosal resection; the rate of metastasis is 4%, compared to a rate of metastasis of 35% in tumors with submucosal spread. In this review, the history of endscopic mucosal resection is reviewed, including the factors that have refined the technique and technical aspects crucial for effective results. The importance of adequate submucosal injection of dilute epinephrine in saline solution is particularly emphasized. The overall efficacy, low rate of complications and such practical aspects as post-therapeutic care are discussed. In general, mucosal cancers of the gastrointestinal tract have no risk of lymph node metastases and can be curatively managed by refined endoscopic mucosal resection procedures. Copyright 2002 Blackwell Publishing Asia Pty Ltd

Entities:  

Mesh:

Year:  2002        PMID: 11982716     DOI: 10.1046/j.1440-1746.2002.02732.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  14 in total

Review 1.  How good is endoscopic ultrasound for TNM staging of gastric cancers? A meta-analysis and systematic review.

Authors:  Srinivas-Reddy Puli; Jyotsna Batapati Krishna Reddy; Matthew L Bechtold; Mainor R Antillon; Jamal A Ibdah
Journal:  World J Gastroenterol       Date:  2008-07-07       Impact factor: 5.742

Review 2.  Endoscopic mucosal resection for early gastric cancer.

Authors:  Cathy Bennett; Yiping Wang; Tao Pan
Journal:  Cochrane Database Syst Rev       Date:  2009-10-07

Review 3.  Endoscopic treatments for dysplastic Barrett's esophagus: resection, ablation, what else?

Authors:  Charumathi Raghu Subramanian; George Triadafilopoulos
Journal:  World J Surg       Date:  2015-03       Impact factor: 3.352

4.  Biological ablation of sentinel lymph node metastasis in submucosally invaded early gastrointestinal cancer.

Authors:  Satoru Kikuchi; Hiroyuki Kishimoto; Hiroshi Tazawa; Yuuri Hashimoto; Shinji Kuroda; Masahiko Nishizaki; Takeshi Nagasaka; Yasuhiro Shirakawa; Shunsuke Kagawa; Yasuo Urata; Robert M Hoffman; Toshiyoshi Fujiwara
Journal:  Mol Ther       Date:  2014-12-19       Impact factor: 11.454

Review 5.  Endoscopic approaches for early-stage esophageal cancer: current options.

Authors:  Vaishali Patel; Rebecca A Burbridge
Journal:  Curr Oncol Rep       Date:  2015-01       Impact factor: 5.075

Review 6.  Nonsurgical approaches to esophageal malignancy.

Authors:  Darius Sorbi; David E Fleischer
Journal:  Curr Gastroenterol Rep       Date:  2003-06

Review 7.  Management controversies in Barrett's oesophagus.

Authors:  L Max Almond; Hugh Barr
Journal:  J Gastroenterol       Date:  2013-06-05       Impact factor: 7.527

8.  The role of surgery after incomplete endoscopic mucosal resection for early gastric cancer.

Authors:  Yoo Seung Chung; Do-Joong Park; Hyuk-Joon Lee; Sang-Gyun Kim; Hyun-Chae Jung; In-Sung Song; Woo-Ho Kim; Kuhn-Uk Lee; Kuk-Jin Choe; Han-Kwang Yang
Journal:  Surg Today       Date:  2007-01-25       Impact factor: 2.540

9.  Management of Barrett's oesophagus.

Authors:  Jayan Mannath; Krish Ragunath
Journal:  F1000 Med Rep       Date:  2009-01-21

10.  Different solutions used for submucosal injection influenced early healing of gastric endoscopic mucosal resection in a preclinical study in experimental pigs.

Authors:  Jan Bures; Marcela Kopácová; Jaroslav Kvetina; Jan Osterreicher; Zuzana Sinkorová; Zbynek Svoboda; Ilja Tachecí; Stanislav Filip; Stanislav Spelda; Martin Kunes; Stanislav Rejchrt
Journal:  Surg Endosc       Date:  2008-12-05       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.